Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026

Aytu BioPharma (Nasdaq: AYTU) will report operational and financial results for its fiscal 2026 third quarter after market close on Wednesday, May 13, 2026.

Rhea-AI Summary

Aytu BioPharma (Nasdaq: AYTU) will report operational and financial results for its fiscal 2026 third quarter after market close on Wednesday, May 13, 2026. A conference call and webcast to review results is scheduled the same day at 4:30 p.m. ET.

Dial-in access, a live webcast link, and a teleconference replay through May 27, 2026, are available for investors and analysts.

Argus May 7 session

-3.52% close to close Open Argus

Details

News Market Reaction – AYTU

In the May 7 session, AYTU declined 3.52%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for AYTU’s fiscal 2026 Q3 results on May 13, 2026, with a confe...

Analysis

This announcement sets the timetable for AYTU’s fiscal 2026 Q3 results on May 13, 2026, with a conference call at 4:30 p.m. ET. It continues the company’s pattern of pre-announcing reporting dates and access details. In light of prior quarters, investors may watch upcoming disclosures on revenue trends, EXXUA uptake, derivative warrant liabilities, and cash position. The call and replay logistics give stakeholders structured opportunities to assess any operational or balance sheet developments.

Key Figures

Earnings release date: May 13, 2026 Conference call time: 4:30 p.m. Eastern time US dial-in number: (888) 506-0062 +5 more

Earnings release date

May 13, 2026

Fiscal 2026 Q3 operational and financial results after market close

Conference call time

4:30 p.m. Eastern time

Fiscal 2026 Q3 results call on May 13, 2026

US dial-in number

(888) 506-0062

Access for United States callers to Q3 earnings call

International dial-in

+1 (973) 528-0011

Access for international callers to Q3 earnings call

Participant access code

273453

Code required to join Q3 fiscal 2026 conference call

Replay end date

May 27, 2026

Teleconference replay availability for Q3 earnings call

US replay number

(877) 481-4010

Telephone replay access for United States callers

Replay access code

53861

Code required to access teleconference replay

Previous Earnings date Reports

1 past event · Latest: Jan 27

Same Type 1 event

1. Jan 27

   Earnings date notice

   24h Move

   +0.8%

   Announced timing and access details for fiscal 2026 Q2 results call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DENVER, CO / ACCESS Newswire / May 6, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its third quarter of fiscal 2026, after the market close on Wednesday, May 13, 2026. The Company has scheduled a conference call and webcast that same day, Wednesday, May 13, 2026, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.

Conference Call Details

Date and Time: Wednesday, May 13, 2026, at 4:30 p.m. Eastern time.

Call-in Information: Interested parties can access the conference call by dialing (888) 506-0062 for United States callers or +1 (973) 528-0011 for international callers and using the participant access code 273453.

Webcast Information: The webcast will be accessible live and archived at https://www.webcaster5.com/Webcast/Page/2142/53861, and accessible on the Investors section of the Company's website at https://investors.aytubio.com/ under Events & Presentations.

Replay: A teleconference replay of the call will be available until May 27, 2026, at (877) 481-4010 for United States callers or +1 (919) 882-2331 for international callers and using replay access code 53861.

About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), and treatments for attention deficit-hyperactivity disorder (ADHD). Aytu is committed to delivering the Company's medications through best-in-class patient access programs that help to enable optimal patient outcomes. For more information, please visit aytubio.com or follow us on LinkedIn.

Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
rselhorn@aytubio.com

Robert Blum
Lytham Partners
aytu@lythampartners.com

SOURCE: Aytu BioPharma, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Aytu BioPharma (AYTU) report Q3 fiscal 2026 results?

Aytu will report fiscal 2026 third-quarter results after market close on May 13, 2026. According to the company, results will be followed by a conference call and webcast the same day at 4:30 p.m. ET to review results and take questions.

How can investors join the Aytu BioPharma (AYTU) May 13, 2026 conference call?

U.S. participants can dial (888) 506-0062 and international callers +1 (973) 528-0011 using access code 273453. According to the company, the call begins at 4:30 p.m. ET on May 13, 2026, followed by a Q&A session.

Where can I watch the Aytu BioPharma (AYTU) webcast for May 13, 2026 results?

The live and archived webcast is available at the specified webcaster link and on the company's investor site under Events & Presentations. According to the company, the webcast will be accessible live and archived for later viewing.

Will there be a replay of the Aytu BioPharma (AYTU) May 13, 2026 earnings call?

Yes. A teleconference replay is available until May 27, 2026 by calling (877) 481-4010 (U.S.) or +1 (919) 882-2331 (international) using replay code 53861. According to the company, replay details are provided for investor access.

What time is the Aytu BioPharma (AYTU) earnings call on May 13, 2026?

The earnings call and webcast are scheduled for 4:30 p.m. Eastern time on May 13, 2026. According to the company, the event occurs after market close and includes a results review followed by a question-and-answer session.